Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2008 · third_quarter · Q3
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Source: Senate LDA
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Enhancing Drug Safety and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Enhancing Drug Safety and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Enhancing Drug Safety and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
S. 1145, Patent Reform Act of 2007, entire bill HR 1908, Patent Reform Act of 2007, entire bill
S.1145, Patent Reform Act of 2007, entire bill H.R.1908, Patent Reform Act of 2007, entire bill
S. 1145, Patent reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Safeguarding America's Pharmaceuticals Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Safeguarding America's Pharmaceuticals Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
S. 1145, Patent Reform Act of 2007, entire bill HR 1908, Patent Reform Act of 2007, entire bill
S.1145, Patent Reform Act of 2007, entire bill H.R.1908, Patent Reform Act of 2007, entire bill
S. 1145, Patent reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
340B Program Improvement and Integrity Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Affordable Biologics for Consumers Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Affordable Biologics for Consumers Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Affordable Biologics for Consumers Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Biologics Price Competition and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Biologics Price Competition and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Biologics Price Competition and Innovation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Physician Payments Sunshine Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Medicare Funding Warning Response Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Medicare Improvements for Patients and Providers Act of 2008
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
Safe Internet Pharmacy Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Safe Internet Pharmacy Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Safe Internet Pharmacy Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R.1038, Access to Life-Saving Medicine Act, follow-on biologics H.R.1561, Enhancing Drug Safety and Innovation Act of 2007 H.R.1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S.1505, Affordable Biologics for Consumers Act, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S.596, Safe Internet Pharmacy Act of 2007 S. 623, Acces to Life-Saving Medicine Act, follow-on biologics H.R.5629, Pathway for Biosimilars Act H.R.5839, Safeguarding America's Pharmaceuticals Act
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
Access to Life-Saving Medicine Act
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Small Business Expensing Permanency Act of 2003
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
FY09 Administration Budget House Concurrent Resolution 312 FY09 Revised Congressional Budget Senate Concurrent Resolution 70 FY09 Congresssional Budget Comparative Effectiveness FDA/ Drug Importation H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act of 2009
Small Business Expensing Permanency Act of 2003
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Comparative Effectiveness LHHS Appropriations Diabetes Research Issues H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act of 2009
Issues regarding H.R.1908 and S.1145 dealing with patent reform legislation.
Issues regarding HR 1908 and S 1145 dealing with patent reform legislation.
Issues regarding HR 1908 and S 1145 dealing with patent reform legislation.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Issues regarding implementation of Medicaid Part D Prescription Program; non-interference; HR4.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: AMYLIN PHARMACEUTICALS · Firm: AMYLIN PHARMACEUTICALS
Issues regarding implementation of Medicaid Part D Prescription Program; non-interference; HR4.
Issues regarding HR 1908 and S 1145 dealing with patent reform legislation.
Issues regarding HR 1908 and S 1145 dealing with patent reform legislation.
Issues regarding H.R.1908 and S.1145 dealing with patent reform legislation.
Extension of the R&D Tax Credit
Comparative Effectiveness LHHS Appropriations Diabetes Research Issues H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act of 2009
FY09 Administration Budget House Concurrent Resolution 312 FY09 Revised Congressional Budget Senate Concurrent Resolution 70 FY09 Congresssional Budget Comparative Effectiveness FDA/ Drug Importation H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act of 2009
H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R.3162, Childrens Health and Medicare Protection Act of 2007 S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008
S.1145, Patent Reform Act of 2007, entire bill H.R.1908, Patent Reform Act of 2007, entire bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2008 · second_quarter · Q2
H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R., Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
LHHS Appropriations Diabetes Research Issues Comparative Effectiveness
S. 1145, Patent reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill
Extension of the R&D Tax Credit
Comparative Effectiveness FY09 Administration Budget House Concurrent Resolution 312, FY09 Revised Congressional Budget Senate Concurrent Resolution 70, FY09 Congressional Budget FDA/drug importation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2008 · first_quarter · Q1
S. 1145, Patent Reform Act of 2007, entire bill HR 1908, Patent Reform Act of 2007, entire bill
Comparative Effectiveness Diabetes research issues LHHS appropriations
FY09 Adminstration Budget House Concurrent Resolution 312 FY09 Revised Congressional Budget Senate Concurrent Resolution 70 FY09 Congresisonal Budget Comparative Effectiveness FDA/drug importation
HR 2606, 340B Program Improvement and Intergrity Act, 340B drug price expansion HR 3162, Children Health and Medicare Protection Act of 2007 HR 4, Medicare Precription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 5480, Medicare Funding Warning Response of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2007 · mid_year · MA
Issues regarding implementation of Medicaid Part D Prescription Program; non-interference; HR4.
Issues regarding drug importation and general diabetes legislation.
Issues regarding HR 1908 and S 1145 dealing with patent reform legislation.
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2007 · mid_year · MA
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2007 · year_end · YY
Issues regarding drug importation and general diabetes legislation.
Issues regarding the Prescription Drug User Fee Act (PDUFA) and drug safety.
Issues regarding H.R.1908 and S.1145 dealing with patent reform legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMYLIN PHARMACEUTICALS via AMYLIN PHARMACEUTICALS
2007 · mid_year · MM
Issues regarding HR 1908 and S 1145 dealing with patent reform legislation.
Issues regarding the Prescription Drug User Fee Act [PDUFA] and drug safety.
Issues regarding drug importation and general diabetes legislation.
Issues regarding implementation of Medicaid Part D Prescription Program; non-interference; HR4.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE